IL6 and neoplasm: In contrast, excessive levels of circulating IL-6 are observed in advanced ovarian cancers and this may be contributed by either tumour cells or peritoneal mesothelial cells, both of which are major contributors to IL-6 production within the tumour microenvironment31,32.